Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

A Combination of Antibiotics to Decrease Neonatal Morbidity and Mortality for Previable Threatened Labor

NCT: NCT06572761 · NOT_YET_RECRUITING

NCT IDNCT06572761
StatusNOT_YET_RECRUITING
Start Date2026-09
Completion2030-05

Brief Summary

The purpose of this study is to determine whether a combination of antibiotics (cephalosporin 3rd generation, clarithromycin, metronidazole) are effective to prolong pregnancies complicated with previable threatened labour with intact membranes.

Frequently Asked Questions

What is A Combination of Antibiotics to Decrease Neonatal Morbidity and Mortality for Previable Threatened Labor?

A Combination of Antibiotics to Decrease Neonatal Morbidity and Mortality for Previable Threatened Labor is a clinical trial registered under NCT06572761. Current status: NOT_YET_RECRUITING.

What is the status of NCT06572761?

The current status of NCT06572761 (A Combination of Antibiotics to Decrease Neonatal Morbidity and Mortality for Previable Threatened Labor) is: NOT_YET_RECRUITING.

When did A Combination of Antibiotics to Decrease Neonatal Morbidity and Mortality for Previable Threatened Labor start?

A Combination of Antibiotics to Decrease Neonatal Morbidity and Mortality for Previable Threatened Labor started on 2026-09.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑